RAPT, Jeyou are itching to start Phase 3 after encouraging mid-stage results in urticaria

RAPT Therapeutics' partner Shanghai Jeyou Pharmaceutical intends to put the itch therapy that they are developing into late-stage trials following a positive showing in Phase 2. The China-based trial conducted by Jeyou assessed the anti ...